glp-1 shortage canada news today GLP-1 prescription trends through March 2026 What happens when demand outpaces

We focus on appetite control, metabolic balance, and sustainable fat loss through customized medication dosing, nutrition, and lifestyle guidance

In individuals with T2DM, the risk of fractures was assessed using a network meta-analysis and systematic review to determine the relationship between dipeptidyl peptidase-4 inhibitors (DPP-4i), GLP-1 RAs, and sodium-glucose cotransporter-2 inhibitors (SGLT-2i)

Less common but involves distinct surgical planning

Should I consider an SGLT2 inhibitor instead of or in addition to a GLP-1 medication, especially if I have heart failure or kidney disease

Design In the obesity trial, 338 participants (mean age 48 years, 48% women, mean BMI 37.3 kg/m 2 ) were randomised (2:1:1:1:1:2:2) to retatrutide 1 mg, 4 mg (titration), 4 mg (no titration), 8 mg (slow titration), 8 mg (fast titration), 12 mg or placebo over 48 weeks [45]

Clinicians should also be cautious in the case of T2D patients receiving drugs that inhibit the renin-angiotensin system